Back to mobile site

BTIG Reiterates Buy Rating on MDxHealth SA (MDXH)

August 23, 2024 5:05 AM EDT Send to a Friend
BTIG analyst Mark Massaro reiterated a Buy rating and $8.00 price target on MDxHealth SA (NASDAQ: MDXH)The analyst comments "As ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login